Acupuncture and Moxibustion Department, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Medicine (Baltimore). 2024 Jun 7;103(23):e38403. doi: 10.1097/MD.0000000000038403.
Electroacupuncture (EA) is considered as an effective treatment for urinary retention (UR).
Up to April 7, 2023, randomized controlled trials (RCTs) of EA for UR were extensively searched in 8 databases, including Pubmed, Cochrane, Embase, Web of Science, Chinese Biomedical Literature Database, Chinese Journal Full-text Database, Wanfang Data, and VIP Full-text e-Journals Database. The Cochrane Risk of Bias tool and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) were utilized to evaluate the quality of all included RCTs. Meta-analysis was conducted using Stata 15.0 software.
A total of 23 trials were included, and the meta-analysis results suggested that compared with the control group, EA can effectively treat various types of UR (risk ratio [RR] = 1.22, 95CI%: 1.14, 1.31) and promote bladder function recovery, with a significant reduce in residual urine volume (weighted mean differences [WMD] = -49.60, 95CI%: -64.10, -35.11), an increase in maximum bladder capacity (WMD = 47.00, 95CI%: 12.76, 81.24), a shorten in the first urination time (standardized mean difference [SMD] = -1.42, 95CI%: -2.08, -0.76), and less adverse reactions (RR = 0.21, 95CI%: 0.07, 0.65).
EA has significant advantages in treating UR, but the efficacy and safety are still needed to be further verified through large-sample and high-quality RCTs.
电针(EA)被认为是治疗尿潴留(UR)的有效方法。
截至 2023 年 4 月 7 日,在 8 个数据库(包括 PubMed、Cochrane、Embase、Web of Science、中国生物医学文献数据库、中国期刊全文数据库、万方数据和 VIP 全文电子期刊数据库)中广泛搜索了 EA 治疗 UR 的随机对照试验(RCT)。使用 Cochrane 偏倚风险工具和推荐评估、制定与评价(GRADE)对所有纳入的 RCT 进行质量评估。使用 Stata 15.0 软件进行荟萃分析。
共纳入 23 项试验,荟萃分析结果表明,与对照组相比,EA 能有效治疗各种类型的 UR(风险比 [RR] = 1.22,95%置信区间:1.14,1.31),促进膀胱功能恢复,显著减少残余尿量(加权均数差 [WMD] = -49.60,95%置信区间:-64.10,-35.11),增加最大膀胱容量(WMD = 47.00,95%置信区间:12.76,81.24),缩短首次排尿时间(标准化均数差 [SMD] = -1.42,95%置信区间:-2.08,-0.76),不良反应较少(RR = 0.21,95%置信区间:0.07,0.65)。
EA 在治疗 UR 方面具有显著优势,但仍需要通过大样本、高质量的 RCT 进一步验证其疗效和安全性。